Novo Nordisk A/S ADR (NVO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2003 | 12-2002 | 09-2002 | 06-2002 | 03-2002 | |
| Cash Flows From Operating Activities | |||||
| Net Income | N/A | 576,000 | N/A | N/A | N/A |
| Depreciation Amortization | N/A | 187,000 | N/A | N/A | N/A |
| Other Working Capital | N/A | -100,000 | N/A | N/A | N/A |
| Other Operating Activity | 0 | 23,000 | 0 | 0 | 0 |
| Operating Cash Flow | $N/A | $686,000 | $N/A | $N/A | $N/A |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | -549,000 | N/A | N/A | N/A |
| Net Acquisitions | N/A | -56,000 | N/A | N/A | N/A |
| Other Investing Activity | 0 | -11,000 | 0 | 0 | 0 |
| Investing Cash Flow | $N/A | $-616,000 | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Dividend Paid | N/A | -162,000 | N/A | N/A | N/A |
| Other Financing Activity | 0 | -52,000 | 0 | 0 | 0 |
| Financing Cash Flow | $N/A | $-214,000 | $N/A | $N/A | $N/A |
| Exchange Rate Effect | N/A | -4,000 | N/A | N/A | N/A |
| Beginning Cash Position | N/A | 321,000 | N/A | N/A | N/A |
| End Cash Position | N/A | 173,000 | N/A | N/A | N/A |
| Net Cash Flow | $N/A | $-148,000 | $N/A | $N/A | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | N/A | 686,000 | N/A | N/A | N/A |
| Free Cash Flow | 0 | 686,000 | 0 | 0 | 0 |